SGLT2i use linked to lower risk for neurodegenerative disease in T2DM
By
HealthDay News
Sep 18, 2024
A reduced risk for Alzheimer’s disease, vascular dementia and Parkinson’s disease was seen with SGLT2i use in type 2 diabetes.
Vision impairment contributes to dementia risk
By
Haymarket Media
Sep 11, 2024
Population-level dementia-attributable fractions from at least one visual impairment were highest among subpopulations of participants aged 71 to 79 years, female individuals and non-Hispanic white individuals,...
No spike in schizophrenia, other diagnoses among people with dementia after feds crack down on antipsychotic...
By
Kimberly Marselas
Aug 28, 2024
Federal policies designed to reduce use of antipsychotic medications in nursing homes did not lead to clinically significantly higher rates of schizophrenia diagnoses among people living with dementia,...
Risk for dementia similar with SGLT2 inhibitors, dulaglutide in T2DM
Aug 26, 2024
The estimated risk difference varied from −2.45 to 0.63 percentage points with SGLT2 versus dulaglutide among older adults.
Regional variation seen in Alzheimer’s and related dementia diagnosis
Aug 19, 2024
The ADRD-specific diagnosis intensity varies most for Black, Hispanic and youngest subgroups.
Studies highlight increasing dementia deaths, contributing factors to diagnosis and cognitive decline
By
Kimberly Bonvissuto
Aug 16, 2024
More people are dying from dementia, and location and demographics are among the factors that may contribute to not only a dementia diagnosis, but also to how quickly someone will experience cognitive...
To know or not to know, that is the question
By
John O'Connor
Aug 15, 2024
We live in an era where finding answers quickly is highly valued. But is faster always better?
Researcher eyes assisted living as base for testing AI-powered dementia screening technology
By
Kimberly Bonvissuto
Aug 14, 2024
A research-based startup is looking to assisted living providers as it works to commercialize its artificial intelligence-powered platform to improve the dementia screening process.
Personalized health coaching may improve cognition, lower dementia risk in high-risk older adults
By
Kimberly Bonvissuto
Aug 13, 2024
Personalized dementia risk reduction intervention plans improved cognition and reduced dementia risk among high-risk older adults in a study detailed recently in JAMA Internal Medicine.
Prevalence of homebound 22 percent in national Medicare Advantage plan
Aug 12, 2024
Homebound status linked to increased odds of ED visit, inpatient admission, skilled nursing-facility admission, mortality